Introduction: Endometrial cancer is one of the most common gynaecological cancers. It mainly develops in postmenopausal women and is often diagnosed at a late stage. The aim of this study was to contribute to the study of endometrial cancers. Methods: This was a retrospective descriptive study covering a 10-year period (1 January 2015 to 31 December 2024) focusing on endometrial biopsy specimens and curettage samples received by the department during the study period. Results: Over a 10-year period, we collected 55 cases of endometrial cancer, representing 6.50% of uterine organic pathologies. Patients in the 60-70 age group were the most affected (34.54%). The average age was 46.2 years, with extremes of 29 and 86 years. The majority were nulliparous and primiparous in 34.54% and 25.45% of cases, respectively. Metrorrhagia was the main reason for consultation in 92.72% of cases. Biopsy was indicated for suspected endometrial cancer in 30.90% of cases. The samples examined were mainly from hysterectomy specimens (70.90%). Macroscopically, 60% of cases involved ulcerative-budding lesions and 65.45% involved diffuse localisation. Histologically, endometrioid carcinoma was the most common type (70.90%) and was limited to the myometrium in 46.15% of cases. Histological grades 2 and 3 were the most commonly observed, accounting for 27.27% and 54.54% of cases, respectively. Conclusion: Pathological examination is the only way to confirm a diagnosis of endometrial cancer. In order to limit the margin of diagnostic error, it is necessary to take a representative sample during the biopsy.
| Published in | International Journal of Clinical Oncology and Cancer Research (Volume 10, Issue 4) |
| DOI | 10.11648/j.ijcocr.20251004.16 |
| Page(s) | 167-171 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2025. Published by Science Publishing Group |
Endometrial Cancer, Pathological Anatomy, Conakry University Hospital, Guinea
Year | Number (N=55) | % |
|---|---|---|
2015 | 03 | 5.4 |
2016 | 02 | 3.6 |
2017 | 04 | 7.3 |
2018 | 04 | 7.3 |
2019 | 03 | 5.4 |
2020 | 04 | 7.3 |
2021 | 06 | 10.9 |
2022 | 07 | 12.7 |
2023 | 10 | 18.2 |
2024 | 12 | 21.8 |
Total | 55 | 100 |
Number (N=55) | % | |
|---|---|---|
Age | ||
<30 | 01 | 1.8 |
30-39 | 03 | 5.5 |
40-49 | 03 | 5.5 |
50-59 | 08 | 14.5 |
60-69 | 19 | 34.5 |
70-79 | 14 | 25.5 |
>79 | 07 | 12.7 |
Parity | ||
Nulliparous | 19 | 34.5 |
Primiparous | 14 | 25.5 |
Paucipara | 10 | 18.2 |
Multipara | 12 | 21.8 |
Number (N=55) | % | |
|---|---|---|
Reason for consultation | ||
Abdominal and pelvic pain | 47 | 85.5 |
Abdominal mass | 43 | 78.2 |
Leucorrhoea | 27 | 49.1 |
Metrorrhagia | 51 | 92,7 |
Hydrorrhoea | 50 | 90,9 |
Initial clinical diagnosis | ||
Endometrial cancer | 17 | 30.9 |
Endometrial tumour | 14 | 25.4 |
Uterine tumour | 09 | 16.4 |
Endometrial hyperplasia | 15 | 27.3 |
Type of sample | ||
Curettage core sample | 15 | 27.2 |
Hysterectomy | 39 | 71.0 |
Hysteroscopic biopsy core sample | 01 | 1.8 |
Number (N=55) | % | |
|---|---|---|
Seat | ||
Diffuse | 36 | 65.5 |
Uterine fundus | 04 | 7.3 |
Right horn | 01 | 1.8 |
Left horn | 02 | 3.6 |
Isthmus | 01 | 1.8 |
Anterior surface | 06 | 11.0 |
Posterior surface | 05 | 9.0 |
Macroscopic appearance | ||
Buddling | 08 | 14.5 |
Ulcerative-budding | 33 | 60.0 |
Ulcerative | 09 | 16.4 |
Infiltrative | 05 | 9.1 |
Histological type or microscopy | ||
Endometrioid adenocarcinoma (Type 1) | 39 | 71.0 |
Clear cell adenocarcinoma | 08 | 14.5 |
Sarcoma | 02 | 3.6 |
Carcinosarcoma | 01 | 1.8 |
Lymphoma | 02 | 3.6 |
Metastasis | 03 | 5.5 |
Histological grade | ||
Grade 1 | 10 | 18.2 |
Grade 2 | 15 | 27.3 |
Grade 3 | 30 | 54.5 |
N | Nomber |
| [1] | Boronow RC, Morrow CP, Creasman WT, Disaia PJ, Silverberg SG, Miller A, et al. Surgical staging in endometrial cancer: clinicalpat hologic findings of a prosp ective study. Obstet Gynecol 2014; 63: 82 5-32. |
| [2] | Larson DM, Connor GP, Broste SK, Krawisz BR, Johnson KK. Prognostic sign ificance of gross myometrial invasion with endometrial cancer. Obstet Gynecol 2016; 88: 394-8. |
| [3] | Kodama S, Kase H, Tanaka K, Matsui K. Multivariate analysis of prognostic factors in patients with endometrial cancer. Int J Gynae col Obstet 2016; 53: 23-30. |
| [4] | Manfredi R, Mirk P, Maresca G, Margariti PA, Testa A, Zannoni GF, et al. Local regional staging of endometrial carcinoma: role of MR imaging in surgical planning. Radiology 2014; 231: 372-8. |
| [5] | Taïeb S, Ceugnart L, Leblanc E, Chevalier A, Cabaret V, Querleu D. MR Imaging of endometrial carcinoma: role and limits. Bull Can cer 2012; 89: 963-8. |
| [6] | Kinkel K, Kaji Y, Kyle K. et al. Radiologic staging in patients with endometrial cancer: a meta-analysis. Radiology 2019; 22: 71-78. |
| [7] | Rieck GC, Bulman J, Whitaker R, Leeson SC. A retrospective revi ew of magnetic resonance imaging in assessing the extent of myom etrial infiltration for patients with endometrial carcinoma. J Obstet Gynaecol 2015; 25: 765-8. |
| [8] | Nasi F, Fiocchi F, Pecchi A, Rivasi F, Torricelli P. MRI evaluation of myometrial invasion by endometrial carcinoma. Comparison between fast-spin-echo T2w and coronal-FMPSPGR Gadolinium-Dota-enhanced sequences. Radiol Med (Torino) 2015; 110: 199-210. |
| [9] | Utsunomiya D, Notsute S, Hayashida Y, Lwakatare F, Katabuchi H, Okamura H, et al. Endometrial carcinoma in adenomyosis: assess ment of myometrial invasion on T2-weighted spin-echo and gadolinum-enhanced T1-weighted images. Am J Roentgenol 2014; 182: 399-404. |
| [10] | Narducci F, Lambaudie E, Sonoda Y, et al. Endometrial cancer: what’s new? Gynecol Obstet Fertil 2013; 31: 581-96. |
| [11] | Mariani A, Keeney GL, Aletti G, Webb MJ, Haddock MG, PodratzKC. Endom etrialcarcinoma: paraaorticdissemination. Gynecol Oncol 2014; 92: 833-8. 8. |
| [12] | Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. A gynecologic oncology group study. Cancer 1987; 60(8 suppl.): 2015-41. |
| [13] | Hidaka T, Kato K, Yonezawa R, et al. Omission of lymphadenectomy is possible for low-risk corpus cancer. Eur J Surg Oncol 2017; 33: 86-90. |
| [14] | Raoudha Doghri, Yosra Yahyaoui, Azza Gabsi, Maha Driss, Nadia Boujelbene, Lamia Charfi, Mezlini Amel et coll: Les carci nomes de l’endomètre: Etude anatomopathologique et histopronos tique à propos de 62 cas dans un centre du nord tunisien: Elsevier Masson 2017.12.20-27. |
| [15] | La Russa. M., Zapardiel. I., Halaska. MI., et coll: Prise en charge conservatrice du cancer de l’endomètre: une enquête auprès de cliniciens européens: Published online Juin 2018; 4820-7. |
| [16] | Leblanc. E., V. Samouelian, L. Boulanger, F. Narducci: Ya-t-il encore des contre-indications à la laparoscopie dans le traitement chirurgical des cancers de l’endomètre ? Elsevier Masson 2015; (38): 119-125. |
| [17] | Peignaux. K., Truc. G., Blanchard. N., Créhange. G., et coll. Maingon: Cancer de l’endomètre dé stade 1: Elsevier Masson 2018(12): 625-629. |
| [18] | Pointreau. Y., Bernadou. G, Denis. F., Barillot. I. J. Cancer de l’endomètre: Elsevier Masson 2016; 34: 154-160. |
APA Style
Ibrahima, C., Abdoulaye, S., Momo, S. A. F., Mohamed, S., Binta, D. F., et al. (2025). Endometrial Cancer in the Pathological Anatomy Department of the Conakry University Hospital (Guinea): 55 Cases over 10 Years (2015–2024). International Journal of Clinical Oncology and Cancer Research, 10(4), 167-171. https://doi.org/10.11648/j.ijcocr.20251004.16
ACS Style
Ibrahima, C.; Abdoulaye, S.; Momo, S. A. F.; Mohamed, S.; Binta, D. F., et al. Endometrial Cancer in the Pathological Anatomy Department of the Conakry University Hospital (Guinea): 55 Cases over 10 Years (2015–2024). Int. J. Clin. Oncol. Cancer Res. 2025, 10(4), 167-171. doi: 10.11648/j.ijcocr.20251004.16
AMA Style
Ibrahima C, Abdoulaye S, Momo SAF, Mohamed S, Binta DF, et al. Endometrial Cancer in the Pathological Anatomy Department of the Conakry University Hospital (Guinea): 55 Cases over 10 Years (2015–2024). Int J Clin Oncol Cancer Res. 2025;10(4):167-171. doi: 10.11648/j.ijcocr.20251004.16
@article{10.11648/j.ijcocr.20251004.16,
author = {Conte Ibrahima and Sylla Abdoulaye and Soumah Aboubacar Fode Momo and Sylla Mohamed and Diallo Fatoumata Binta and Diallo Abdourahamane and Sy Telly and Keita Namory},
title = {Endometrial Cancer in the Pathological Anatomy Department of the Conakry University Hospital (Guinea): 55 Cases over 10 Years (2015–2024)},
journal = {International Journal of Clinical Oncology and Cancer Research},
volume = {10},
number = {4},
pages = {167-171},
doi = {10.11648/j.ijcocr.20251004.16},
url = {https://doi.org/10.11648/j.ijcocr.20251004.16},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcocr.20251004.16},
abstract = {Introduction: Endometrial cancer is one of the most common gynaecological cancers. It mainly develops in postmenopausal women and is often diagnosed at a late stage. The aim of this study was to contribute to the study of endometrial cancers. Methods: This was a retrospective descriptive study covering a 10-year period (1 January 2015 to 31 December 2024) focusing on endometrial biopsy specimens and curettage samples received by the department during the study period. Results: Over a 10-year period, we collected 55 cases of endometrial cancer, representing 6.50% of uterine organic pathologies. Patients in the 60-70 age group were the most affected (34.54%). The average age was 46.2 years, with extremes of 29 and 86 years. The majority were nulliparous and primiparous in 34.54% and 25.45% of cases, respectively. Metrorrhagia was the main reason for consultation in 92.72% of cases. Biopsy was indicated for suspected endometrial cancer in 30.90% of cases. The samples examined were mainly from hysterectomy specimens (70.90%). Macroscopically, 60% of cases involved ulcerative-budding lesions and 65.45% involved diffuse localisation. Histologically, endometrioid carcinoma was the most common type (70.90%) and was limited to the myometrium in 46.15% of cases. Histological grades 2 and 3 were the most commonly observed, accounting for 27.27% and 54.54% of cases, respectively. Conclusion: Pathological examination is the only way to confirm a diagnosis of endometrial cancer. In order to limit the margin of diagnostic error, it is necessary to take a representative sample during the biopsy.},
year = {2025}
}
TY - JOUR T1 - Endometrial Cancer in the Pathological Anatomy Department of the Conakry University Hospital (Guinea): 55 Cases over 10 Years (2015–2024) AU - Conte Ibrahima AU - Sylla Abdoulaye AU - Soumah Aboubacar Fode Momo AU - Sylla Mohamed AU - Diallo Fatoumata Binta AU - Diallo Abdourahamane AU - Sy Telly AU - Keita Namory Y1 - 2025/12/29 PY - 2025 N1 - https://doi.org/10.11648/j.ijcocr.20251004.16 DO - 10.11648/j.ijcocr.20251004.16 T2 - International Journal of Clinical Oncology and Cancer Research JF - International Journal of Clinical Oncology and Cancer Research JO - International Journal of Clinical Oncology and Cancer Research SP - 167 EP - 171 PB - Science Publishing Group SN - 2578-9511 UR - https://doi.org/10.11648/j.ijcocr.20251004.16 AB - Introduction: Endometrial cancer is one of the most common gynaecological cancers. It mainly develops in postmenopausal women and is often diagnosed at a late stage. The aim of this study was to contribute to the study of endometrial cancers. Methods: This was a retrospective descriptive study covering a 10-year period (1 January 2015 to 31 December 2024) focusing on endometrial biopsy specimens and curettage samples received by the department during the study period. Results: Over a 10-year period, we collected 55 cases of endometrial cancer, representing 6.50% of uterine organic pathologies. Patients in the 60-70 age group were the most affected (34.54%). The average age was 46.2 years, with extremes of 29 and 86 years. The majority were nulliparous and primiparous in 34.54% and 25.45% of cases, respectively. Metrorrhagia was the main reason for consultation in 92.72% of cases. Biopsy was indicated for suspected endometrial cancer in 30.90% of cases. The samples examined were mainly from hysterectomy specimens (70.90%). Macroscopically, 60% of cases involved ulcerative-budding lesions and 65.45% involved diffuse localisation. Histologically, endometrioid carcinoma was the most common type (70.90%) and was limited to the myometrium in 46.15% of cases. Histological grades 2 and 3 were the most commonly observed, accounting for 27.27% and 54.54% of cases, respectively. Conclusion: Pathological examination is the only way to confirm a diagnosis of endometrial cancer. In order to limit the margin of diagnostic error, it is necessary to take a representative sample during the biopsy. VL - 10 IS - 4 ER -